| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ganciclovir sodium |
Is a |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Ganciclovir measurement |
Component |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir adverse reaction |
Causative agent (attribute) |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Allergy to ganciclovir (finding) |
Causative agent (attribute) |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Ganciclovir 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Ganciclovir 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Ganciclovir [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Ganciclovir 0.15% eye gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Product containing ganciclovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ganciclovir 1.5 milligram/1 gram conventional release eye gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Product containing ganciclovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing ganciclovir in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Ganciclovir-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Allergy to ganciclovir (finding) |
Causative agent (attribute) |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir 250 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir 250 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ganciclovir 1.5 milligram/1 gram conventional release eye gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ganciclovir 1.5 milligram/1 gram conventional release eye gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
|
| Product containing ganciclovir in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ganciclovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Ganciclovir only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ganciclovir (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]